论文部分内容阅读
法玛西亚·普强公司的ＨＩＶ药物地拉韦定甲磺酸盐(ｄｅｌａｖｉｒｄｉｎｅｍｅｓｙｌａｔｅ,商品名Ｒｅｓｃｒｉｐｔｏｒ)已经被美国ＦＤＡ批准上市。而在1996年,ＦＤＡ的一个咨询委员会还不能就是否推荐这个药物达成一致意见。该公司说,它正准备“在3～4个星期之内”以每天6.
The HIV drug delavirdinemesylate (product name Rescriptor) from the Pharmacia Puma company has been approved by the FDA for marketing. In 1996, an FDA advisory committee could not agree on whether to recommend the drug. The company said it is preparing “within 3 to 4 weeks” to 6 per day.